E. Carlsson

Esomeprazole — enhanced bio‐availability, specificity for the proton pump and inhibition of acid secretion

P. Lindberg, T. Andersson, P. Lundborg, 2003, Alimentary pharmacology & therapeutics.

Potassium-competitive acid blockade: a new therapeutic strategy in acid-related diseases.

E. Carlsson, K. Andersson, 2005, Pharmacology & therapeutics.

Early Stellate Cell Activation and Veno-occlusive-disease (VOD)–like Hepatotoxicity in Dogs Treated with AR-H047108, an Imidazopyridine Proton Pump Inhibitor

H. Hellmold, H. Håkansson, R. Huby, 2008, Toxicologic pathology.

A proton-pump inhibitor expedition: the case histories of omeprazole and esomeprazole

Per Lindberg, P. Lindberg, L. Olbe, 2003, Nature Reviews Drug Discovery.

Gastric H,K-ATPase as therapeutic target.

G. Sachs, P. Lindberg, B. Wallmark, 1988, Annual review of pharmacology and toxicology.

Esomeprazole in the Framework of Proton‐Pump Inhibitor Development

P. Lindberg, E. Carlsson, 2006 .